Hostname: page-component-745bb68f8f-5r2nc Total loading time: 0 Render date: 2025-01-14T19:49:08.022Z Has data issue: false hasContentIssue false
  • English
  • Français

Primary Degenerative Dementia Without Alzheimer Pathology

Published online by Cambridge University Press:  18 September 2015

Arthur W. Clark ,
Charles L. White III ,
Herbert J. Manz ,
Irma M. Parhad ,
Bernadette Curry ,
Peter J. Whitehouse ,
John Lehmann  and
Joseph T. Coyle
Arthur W. Clark*
Affiliation:
Departments of Pathology and Clinical Neurosciences, University of Calgary School of Medicine, Calgary
Charles L. White III
Affiliation:
The Department of Pathology, Southwestern Medical School, Dallas, Texas
Herbert J. Manz
Affiliation:
The Departments of Pathology and Neurology, Georgetown University School of Medicine, Washington, D.C.
Irma M. Parhad
Affiliation:
Departments of Pathology and Clinical Neurosciences, University of Calgary School of Medicine, Calgary
Bernadette Curry
Affiliation:
Departments of Pathology and Clinical Neurosciences, University of Calgary School of Medicine, Calgary
Peter J. Whitehouse
Affiliation:
Departments of Neurology and Neuroscience, John Hopkins University School of Medicine, Baltimore, Maryland
John Lehmann
Affiliation:
Department of Neurosciences, CIBA-GEIGY Corporation, Summit, New Jersey
Joseph T. Coyle
Affiliation:
Departments of Psychiatry, Neurosciences, Pharmacology and Pediatrics, John Hopkins University School of Medicine, Baltimore, Maryland
*
Department of Pathology, 11th Floor, Foothills Hospital, 1403 -29th Street, N.W., Calgary, Alberta, Canada T2N 2T9
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

To define the pathology in cases of non-Alzheimer primary degenerative dementia (non-AD PDD), we have studied autopsies from four medical centres accessioned in consecutive years since 1976. Neurochemical studies of the basal forebrain-cortical (BF-C) cholinergic system have been conducted in cases from which frozen tissue was available. Twenty-two cases (mean age 70 years, range 47-86) in which the history was consistent with PDD, but which did not meet anatomic criteria for AD, were selected. Approximately 70 cases of PDD, which were accessioned in the same years and met the anatomic criteria for AD, were excluded. The pathologic findings permitted a classification into six groups: Lewy body disease (LBD), 4 cases; Pick's disease, 6 cases; cortical degeneration with motor neuron disease (CDmnd), 2 cases; hippocampal and temporal lobe sclerosis, 3 cases; few or nonspecific abnormalities, 5 cases; other disorders, 2 cases. Our findings suggest that LBD and Pick's disease account for a large proportion of cases of non-AD PDD in the presenile age group, but that a large number of other disorders occasionally present as PDD. Careful examination of the motor systems, as well as cerebral structures relate' to cognitive function, is important in the neuropathologic evaluation. Lesions of the BF-C cholinergic system have been most consistent and severe in LBD, and have not been identified in CDmnd.

Type
Cellular Clues to Pathogenesis
Information
Canadian Journal of Neurological Sciences , Volume 13 , Issue S4 , November 1986 , pp. 462 - 470
Copyright
Copyright © Canadian Neurological Sciences Federation 1986

References

1.Reisberg, B.Clinical presentation, diagnosis, and symptomatology of age-associated cognitive decline and Alzheimer’s disease. In: Reisberg, B, ed. Alzheimer’s Disease: The Standard Reference. New York: The Free Press 1983; 173–187.Google Scholar
2.Sulkava, R, Haltia, M, Paetau, A, et al. Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathology findings. J Neurol Neurosurg Psychiat 1983; 46: 9–13.CrossRefGoogle Scholar
3.Molsa, PK, Paljarvi, L, Rinne, JO, et al. Validity of clinical diagnosis in dementia: A prospective clinicopathological study. J Neurol Neurosurg Psychiatr 1985; 48: 1085–1090.CrossRefGoogle ScholarPubMed
4.Fox, JH, Penn, R, Clasen, R, et al. Pathological diagnosis in clinically typical Alzheimer’s disease (letter). N Engl J Med 1985; 313: 1419–1420.Google Scholar
5.Smith, WT, Turner, E, and Sim, M.Cerebral biopsy in the investigation of presenile dementia. II. Pathological aspects. Brit J Psychiat 1966; 112: 127–133.CrossRefGoogle ScholarPubMed
6.Sims, NR, Bowen, DM, Smith, CCT, et al. Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer’s disease. Lancet 1980; 1: 333–335.CrossRefGoogle ScholarPubMed
7.Bowen, DM, Benton, JS, Spillane, JA, et al. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci 1982; 57: 191–202.CrossRefGoogle ScholarPubMed
8.Rossor, M, Garrett, NJ, Johnson, AL, et al. A postmortem study of the cholinergic and GABA systems in senile dementia. Brain 1982; 105: 313–330.CrossRefGoogle ScholarPubMed
9.Clark, AW, Manz, HJ, White, CL III, et al. Cortical degeneration with swollen chromatolytic neurons: Its relationship to Pick’s disease. J Neurpathol Exp Neurol 1986; 45: 268–284.CrossRefGoogle ScholarPubMed
10.Bull, G, Oderfeld-Novak, B.Standardization of a radiochemical assay of choline acetyltransferase and a study of the activation of the enzyme in rabbit brain. J Neurochem 1971; 18: 935–941.CrossRefGoogle Scholar
11.Fonnum, F.A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 1975; 24: 407–409.CrossRefGoogle ScholarPubMed
12.Lowry, OH, Rosebrough, NJ, Fair, AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275.CrossRefGoogle ScholarPubMed
13.Clark, AW, Lehmann, J.Dementia with widespread Lewy bodies: Studies of the neocortical cholinergic system. (Abstract), Canadian Association of Neuropathologists, 23rd Annual Meeting, Banff, Alberta, September 1983.Google Scholar
14.Constantinidis, J, Richard, J, Tissot, R.Pick’s disease. Histological and clinical correlations. Europ Neurol 1974; 11: 208–217.CrossRefGoogle ScholarPubMed
15.Clark, AW, Lehmann, J, Whitehouse, PJ, et al. Cortico-striatospinal degeneration (CSSD) mimicking Alzheimer’s disease: Studies of the nucleus basalis of Meynert and cortical choline acetyltransferase. (Abstract) J Neuropathol Exp Neurol 1983; 42: 334.CrossRefGoogle Scholar
16.Yoshimura, M.Cortical changes in the Parkinsonian brain: A contribution to the delineation of “diffuse Lewy body disease”. J Neurol 1983; 229: 17–32.CrossRefGoogle Scholar
17.Woodard, JS.Concentric hyaline inclusion body formation in mental disease: Analysis of twenty-seven cases. J Neuropathol Exp Neurol 1962; 21: 442–449.CrossRefGoogle ScholarPubMed
18.Forno, LS, Barbour, PJ, Norville, RL.Presenile dementia with Lewy bodies and neurofibrillary tangles. Arch Neurol 1978; 35: 818–822.CrossRefGoogle ScholarPubMed
19.Yagishita, S, Itoh, Y, Amano, N, et al. Atypical senile dementia with widespread Lewy type inclusions in the cerebral cortex. Acta Neuropathol (Berl) 1980; 49: 187–191.CrossRefGoogle ScholarPubMed
20.Heilig, CW, Knopman, DS, Mastri, AR, et al. Dementia without Alzheimer pathology. Neurology 1985; 35: 762–765.CrossRefGoogle ScholarPubMed
21.Eggertson, DE, Sima, AAF.Dementia with cerebral Lewy bodies. A mesocortical dopaminergic defect? Arch Neurol 1986; 43: 524–527.CrossRefGoogle ScholarPubMed
22.Hakim, AM, Mathieson, G.Dementia in Parkinson disease: a neuropathology study. Neurology 1979; 29: 1209–1214.CrossRefGoogle Scholar
23.Boiler, F, Mizutani, T, Roessmann, U, et al. Parkinson’s disease, dementia and Alzheimer’s disease: clinicopathological correlations. Ann Neurol 1980; 7: 329–335.CrossRefGoogle Scholar
24.Rosenblum, Wl, Ghatak, NR.Lewy bodies in the presence of Alzheimer’s disease. Arch Neurol 1979; 36: 170–171.CrossRefGoogle ScholarPubMed
25.Gaspar, P, Gray, F.Dementia in idiopathic Parkinson’s disease: A neuropathological study of 32 cases. Acta Neuropathol (Berl) 1984; 64: 43–52.CrossRefGoogle ScholarPubMed
26.Leverenz, J, Sumi, SM.Prevalence of Parkinson’s disease in patients with Alzheimer’s disease. (Abstract) Neurology 1984; 34 (Suppl 1): 101.Google Scholar
27.Mann, DMA, Yates, PO.Pathological basis for neurotransmitter changes in Parkinson’s disease. Neuropathol Appl Neurobiol 1983,9: 3–19.CrossRefGoogle ScholarPubMed
28.Ball, MJ.The morphological basis of dementia in Parkinson’s disease. Can J Neurol Sci 1984; 2: 180–184.CrossRefGoogle Scholar
29.Tagliavini, F, Pilleri, G, Bouras, C, et al. The basal nucleus of Meynert in idiopathic Parkinson’s disease. Acta Neurol Scand 1984; 70: 20–28.CrossRefGoogle ScholarPubMed
30.Ruberg, M, Ploska, A, Javoy-Agid, F, et al. Muscarinic binding and choline acetyltransferase activity in parkinsonian subjects with reference to dementia. Brain Res 1982; 232: 129–139.CrossRefGoogle ScholarPubMed
31.Dubois, B, Ruberg, M, Javoy-Agid, F, et al. A subcortico-cortical cholinergic system is affected in Parkinson’s disease. Brain Res 1983; 288: 213–218.Google ScholarPubMed
32.Perry, RH, Tomlinson, BE, Candy, JM, et al. Cortical cholinergic deficit in mentally impaired Parkinsonian patients (letter). Lancet 1983; 2: 789–790.CrossRefGoogle Scholar
33.Candy, JM, Perry, RH, Perry, EK, et al. Pathological changes in the nucleus of Meynert in Alzheimer’s and Parkinson’s disease. J Neurol Sci 1983; 59: 277–289.CrossRefGoogle Scholar
34.Arendt, T, Bigl, V, Arendt, A, et al. Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s disease, paralysis agitans, and Korsakoff’s disease. Acta Neuropathol (Berl) 1983; 61: 101–108.CrossRefGoogle ScholarPubMed
35.Whitehouse, PJ, Hedreen, JC, White, CL 111, et al. Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 1983; 13: 243–248.CrossRefGoogle ScholarPubMed
36.Hornykiewicz, O, Kish, SJ.Neurochemical basis of dementia in Parkinson’s disease. Can J neurol Sci 1984; 11: 185–190.CrossRefGoogle ScholarPubMed
37.Nakano, I, Hirano, A.Parkinson’s disease: Neuron loss in the nucleus basalis without concomitant Alzheimer’s disease. Ann Neurol 1984; 15: 415–418.CrossRefGoogle ScholarPubMed
38.Adams, RD, Victor, M.Principles of Neurology. Third edition. New York: McGraw-Hill 1985: 866–867.Google Scholar
39.Seitelberger, F, Gross, H, Pilz, P.Pick’s disease: A neuropathologic study. In: Hirano, A, Miyoshi, K, eds. Neuropsychiatrie Disorders in the Elderly. New York: Igaku-Shoin 1981: 87–117.Google Scholar
40.Joachim, CL, Morris, JH, Schoene, WC.Neuropathological findings in six cases of dementia with severe focal atrophy. (Abstract) J Neuropathol Exp Neurol 1986; 45: 361.CrossRefGoogle Scholar
41.Uhl, GR, Hilt, DC, Hedreen, JC, et al. Pick’s disease (lobar sclerosis): Depletion of neurons in the nucleus basalis of Meynert. Neurology 1983; 33: 1470–1473.CrossRefGoogle ScholarPubMed
42.Munoz-Garcia, D, Ludwin, SK.Classical and generalised variants of Pick’s disease. A clinicopathological, ultrastructural, and immunocytochemical comparative study. Ann Neurol 1984; 16: 467–480.CrossRefGoogle ScholarPubMed
43.Yates, CM, Simpson, J, Maloney, AFJ, et al. Neurochemical observations in a case of Pick’s disease. J Neurol Sci 1980; 48:257–263.CrossRefGoogle Scholar
44.Wood, PL, Etienne, P, Lai, S, et al. A post-mortem comparison of the cortical cholinergic system in Alzheimer’s disease and Pick’s disease. J Neurol Sci 1983; 62: 211–217.CrossRefGoogle ScholarPubMed
45.Tagliavini, F, Pilleri, G.Basal nucleus of Meynert. A neuropathological study in Alzheimer’s disease, simple senile dementia, Pick’s disease, and Huntington’schorea. J Neurol Sci 1983;62:243–260.CrossRefGoogle Scholar
46.Case Records ofthe Massachusetts General Hospital (Case 16–1986). N Engl J Med 1986; 314: 1101–1111.Google Scholar
47.Hart, MN, Cancilla, PA, Frommes, S, et al. Anterior horn cell degeneration and Bunina-type inclusions associated with dementia. Acta Neuropathol (Berl) 1977; 38: 225–228.CrossRefGoogle ScholarPubMed
48.Hudson, A.Amyotrophic lateral sclerosis and its association with dementia, Parkinsonism and other neurological disorders: A review. Brain 1981; 104: 217–247.CrossRefGoogle ScholarPubMed
49.Horoupian, DS, Thai, L, Katzman, R, et al. Dementia and motor neuron disease: Morphometric, biochemical, and Golgi studies. Ann Neurol 1984; 16: 305–313.CrossRefGoogle ScholarPubMed
50.Salazar, A, Masters, C, Gajdusek, DC, et al. Syndromes of amyotrophic lateral sclerosis and dementia: Relation to transmissible Creutzfeldt-Jakob disease. Ann Neurol 1983; 14: 17–26.CrossRefGoogle ScholarPubMed
51.Brion, S, Mikol, J, Psimaras, A.Recent findings in Pick’s disease. In: Zimmerman, HM, ed. Progress in Neuropathology, vol. 2. New York: Grune & Stratton, 1973; 421–452.Google Scholar
52.Brion, S, Psimaras, A, Chevalier, JF, et al. L’association maladie de Pick et sclerose latérale amyotrophique. L’Encéphale 1980; 6: 259–286.Google Scholar
53.Mitsuyama, Y, Takamiya, S.Presenile dementia with motor neuron disease in Japan: a new entity. Arch Neurol 1979; 36: 592–593.CrossRefGoogle ScholarPubMed
54.Mitsuyama, Y.Presenile dementia with motor neuron disease in Japan: Clinicopathological review of 26 cases. J Neurol Neurosurg Psychiat 1984; 47: 953–959.CrossRefGoogle ScholarPubMed
55.Hughes, CP, Myers, FK, Smith, K, et al. Nosologic problems in dementia: A clinical and pathologic study of 11 cases. Neurology 1973; 23: 344–351.CrossRefGoogle ScholarPubMed
56.Rogers, JD, Brogan, D, Mirra, SS.The nucleus basalis of Meynert in neurological disease. A quantitative morphological study. Ann Neurol 1985; 17: 163–171.CrossRefGoogle ScholarPubMed
57.Okazaki, H, Reagan, TJ, Campbell, RJ.Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc 1979; 54: 22–31.Google ScholarPubMed
58.Mandybur, Tl.Cerebral amyloid angiopathy: The vascular pathology and complications. J Neuropathol Exp Neurol 1986; 45: 79–90.CrossRefGoogle ScholarPubMed
59.Daniel, SE, Love, S, Scaravilli, F, et al. Encephalomyeloneuropathy in the absence of a detectable neoplasm: Clinical and postmortem findings in three cases. Acta Neuropathol (Berl) 1985; 66: 311–317.CrossRefGoogle ScholarPubMed
60.Duyckaerts, C, Derouesne, C, Signoret, JL, et al. Bilateral and limited amygdalohippocampal lesions causing a pure amnesic syndrome. Ann Neurol 1985; 18: 314–319.CrossRefGoogle ScholarPubMed
61.Henson, RA, Urich, H.Encephalomyelitis with carcinoma. In: Henson, RA, Urich, H.Cancerand the Nervous System. London: Blackwell 1982,314–345.Google Scholar
62.Brierley, JB, Corsellis, JAN, Hierons, R, et al. Subacute encephalitis of later adult life mainly affecting the limbic areas. Brain 1960; 83: 357–368.CrossRefGoogle Scholar
63.Case Records of the Massachusetts General Hospital (Case 30–1985). N Engl J Med 1985; 313: 249–257.Google Scholar
64.Schubert, T, Friede, RL.Transneuronal mammillary atrophy. J Neurol 1979;221:67–72.CrossRefGoogle ScholarPubMed
65.Volpe, BT, Petito, CK.Dementia with bilateral medial temporallobe ischemia. Neurology 1985; 35: 1793–1797.CrossRefGoogle Scholar
66.Heffner, RR, Porro, RS, Olson, ME, et al. A demyelinating disorder associated with cerebrovascular amyloid angiopathy. Arch Neurol 1976; 33: 501–506.CrossRefGoogle ScholarPubMed
67.Feigin, I, Popoff, N.Neuropathological changes late in cerebral edema: The relationship to trauma, hypertensive disease and Binswanger encephalopathy. J Neuropathol Exp Neurol 1963; 22: 500–511.CrossRefGoogle Scholar
68.Martin, JJ.Thalamic degenerations. In: Vinken, PJ, Bruyn, GW, eds. Handbook of Clinical Neurology, vol. 21. New York: Elsevier 1975; 587–604.Google Scholar
69.Neumann, MA, Cohn, R.Progressive subcortical gliosis, a rare form of presenile dementia. Brain 1967; 90: 405–418.CrossRefGoogle ScholarPubMed
70.Davis, PH, Bergeron, C, Mclachlan, DR.Atypical presentation of progressive supranuclear palsy. Ann Neurol 1985; 17: 337–343.CrossRefGoogle ScholarPubMed
71.Brown, P.Johnson, PR, Cathala, F, et al. Creutzfeldt-Jakob disease of long duration: Clinicopathological characteristics, trans-missibility, and differential diagnosis. Ann Neurol 1984; 16: 295–304.CrossRefGoogle ScholarPubMed
72.Mirra, SS, Anand, R, Spira, TJ.HTLV-III/LAV infection of the central nervous system in a 57-year-old man with progressive dementia of unknown cause. (Letter) N Engl J Med 1986; 314: 1191–1192.Google Scholar
73.Fuld, PA, Katzman, R, Davies, P, et al. Intrusion as a sign of Alzheimer dementia: Chemical and pathological verification. Ann Neurol 1982; 2: 155–159.CrossRefGoogle Scholar
74.Tune, L, Gucker, S, Folstein, M, et al. Cerebrospinal fluid acetylcholinesterase activity in senile dementia of Alzheimer type. Ann Neurol 1985; 17: 46–48.CrossRefGoogle Scholar
75.Jagust, WJ, Friedland, RP, Budinger, TF.Positron emission tomography with l8F Fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia. J Neurol Neurosurg Psychiat 1985; 48: 1091–1096.CrossRefGoogle Scholar
76.Neumann, MA, Cohn, R.Degenerative cerebral diseases and their relation to aging. In: Proceedings of the Vllth International Congress of Neuropathology. Amsterdam: Excerpta Medica 1975; 75–78.Google Scholar
77.Tomlinson, BE, Blessed, G, Roth, M.Observations on the brains of non-demented old people. J Neurol Sci 1968; 7: 331–356.CrossRefGoogle ScholarPubMed
78.Tomlinson, BE, Blessed, G, Roth, M.Observations on the brains of demented old people. J Neurol Sci 1970; 11: 205–242.CrossRefGoogle ScholarPubMed
79.Perl, DP, Pendlebury, WW, Bird, ED. Detailed neuropathologic evaluation of banked brain specimens submitted with a clinical diagnosis of Alzheimer’s disease (Abstract). In: Wurtman, RJ.Corkin, SH, Growdon, JH, eds. Proceedings of the Third Meeting of the International Study Group on the Treatment of Memory Disorder Associated with Aging. Center for Brain Sciences and Metabolism Charitable Trust 1984; 463.Google Scholar